Literature DB >> 3692494

Isoniazid overdose: pharmacokinetics and effects of oral charcoal in treatment.

A D Siefkin1, T E Albertson, M G Corbett.   

Abstract

The pharmacokinetics of isoniazid following overdose in two patients is described. One patient was treated with haemodialysis for seizures and persistent coma without obvious immediate clinical improvement. In addition, three volunteer subjects were given isoniazid orally on two separate occasions. Isoniazid elimination pharmacokinetics were determined with and without concominant charcoal. Oral activated charcoal totally prevented the absorption of isoniazid. Current recommendations for treatment of isoniazid overdoses include intravenous pyridoxine (one gram IV pyridoxine for each gram of ingested isoniazid), intravenous diazepam or phenobarbital for continued seizures, and gastric decontamination with lavage and activated charcoal (1 g/kg). Extraordinary measures such as early haemodialysis and haemoperfusion should be reserved for those patients with persistent coma or refractory seizures.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3692494     DOI: 10.1177/096032718700600608

Source DB:  PubMed          Journal:  Hum Toxicol        ISSN: 0144-5952


  5 in total

1.  Isoniazid overdose. Successful treatment with pyridoxine and hemodialysis.

Authors:  J M Cash; E T Zawada
Journal:  West J Med       Date:  1991-12

Review 2.  Clinical applications of commonly used contemporary antidotes. A US perspective.

Authors:  C A Bowden; E P Krenzelok
Journal:  Drug Saf       Date:  1997-01       Impact factor: 5.606

Review 3.  Isoniazid overdose: four case reports and review of the literature.

Authors:  F G Alvarez; K K Guntupalli
Journal:  Intensive Care Med       Date:  1995-08       Impact factor: 17.440

4.  Gastrointestinal decontamination in the acutely poisoned patient.

Authors:  Timothy E Albertson; Kelly P Owen; Mark E Sutter; Andrew L Chan
Journal:  Int J Emerg Med       Date:  2011-10-12

5.  Rapid, Semiquantitative Assay To Discriminate among Compounds with Activity against Replicating or Nonreplicating Mycobacterium tuberculosis.

Authors:  Ben Gold; Julia Roberts; Yan Ling; Landys Lopez Quezada; Jou Glasheen; Elaine Ballinger; Selin Somersan-Karakaya; Thulasi Warrier; J David Warren; Carl Nathan
Journal:  Antimicrob Agents Chemother       Date:  2015-08-03       Impact factor: 5.191

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.